The report was below our estimates on sales, but we found ourselves above analyst consensus, which Q1 sales figures met on sales and surpassed on EBIT. Moreover, Surgical Science’s OPEX was 8% below our forecast, resulting in an EBIT of SEK2m higher than our estimate. We expect the share to trade slightly positive today.
LÄS MER
